Cargando…

Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune(®) System

BACKGROUND: Tumor treating fields (TTFields) are a non-invasive antimitotic therapy that delivers alternating electric fields via the Optune(®) system. The Phase III EF-14 trial in newly diagnosed glioblastoma multiforme (GBM) showed significantly improved progression-free, overall and long-term sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinzel, Adrian, Ambrogi, Michael, Varshaver, Michael, Kirson, Eilon D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351720/ https://www.ncbi.nlm.nih.gov/pubmed/30728735 http://dx.doi.org/10.1177/1179554918825449

Ejemplares similares

NovoTTF(™)-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL(™) system user study
por: Chaudhry, Aafia, et al.
Publicado: (2015)

The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma
por: Doyle, Sean P, et al.
Publicado: (2018)

AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
por: Shteingauz, Anna, et al.
Publicado: (2018)

Stability of Programmable Shunt Valve Settings with Simultaneous Use of the Optune Transducer Array: A Case Report
por: Chan, Andrew K, et al.
Publicado: (2016)

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
por: Fishman, Hila, et al.
Publicado: (2023)

NQPC-9 CHARACTERIZATION AND MANAGEMENT OF DERMATOLOGIC ADVERSE EVENTS WITH OPTUNE® IN WAKAYAMA MEDICAL UNIVERSITY HOSPITAL
por: Fukai, Junya, et al.
Publicado: (2022)

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
por: Voloshin, Tali, et al.
Publicado: (2020)

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
por: Ballo, Matthew T., et al.
Publicado: (2023)

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
por: Porat, Yaara, et al.
Publicado: (2017)

LMAP-12 TUMOR TREATING FIELDS (TTFIELDS) REAL-WORLD EXPERIENCE IN NEWLY DIAGNOSED GLIOBLASTOMA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF OVERALL SURVIVAL
por: Ballo, Matthew T, et al.
Publicado: (2023)

The Value of Tumor Treating Fields in Glioblastoma
por: Zhang, Chaochao, et al.
Publicado: (2020)

Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
por: Giladi, Moshe, et al.
Publicado: (2017)

Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs
por: Kirson, Eilon D., et al.
Publicado: (2009)

Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment
por: Huas, Dominique, et al.
Publicado: (2010)

Current usage of tumor treating fields for glioblastoma
por: Lassman, Andrew B, et al.
Publicado: (2020)

Tumor-Treating Fields in Glioblastomas: Past, Present, and Future
por: Guo, Xiaopeng, et al.
Publicado: (2022)

In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
por: Blatt, Roni, et al.
Publicado: (2021)

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
por: Pandey, Manjari, et al.
Publicado: (2022)

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
por: Rulseh, Aaron Michael, et al.
Publicado: (2012)

Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
por: Toms, S. A., et al.
Publicado: (2018)

Tumor treating fields increases membrane permeability in glioblastoma cells
por: Chang, Edwin, et al.
Publicado: (2018)

Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma
por: Lok, Edwin, et al.
Publicado: (2017)

Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging
por: Soni, Vikram S., et al.
Publicado: (2019)

Enhancing glioblastoma treatment through the integration of tumor-treating fields
por: Szklener, Katarzyna, et al.
Publicado: (2023)

TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters
por: Schneiderman, Rosa S, et al.
Publicado: (2010)

The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
por: Oberheim-Bush, Nancy Ann, et al.
Publicado: (2022)

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
por: Omar, Ayman I.
Publicado: (2014)

The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists
por: Burri, Stuart H., et al.
Publicado: (2018)

Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis
por: Kim, Eun Ho, et al.
Publicado: (2016)

Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
por: Gatson, Na Tosha N., et al.
Publicado: (2021)

The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV
por: Krigers, Aleksandrs, et al.
Publicado: (2022)

IL-2 TUMOR TREATING FIELDS: IMPROVING THE ODDS FOR PATIENTS WITH GLIOBLASTOMA
por: Hottinger, Andreas F
Publicado: (2022)

Tumor treating fields for the treatment of glioblastoma: Current understanding and future perspectives
por: Colamaria, Antonio, et al.
Publicado: (2023)

Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experience
por: Ballo, Matthew T, et al.
Publicado: (2022)

Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
por: Stachelek, Gregory C., et al.
Publicado: (2019)

Corrigendum to: Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
Publicado: (2022)

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
por: Fabian, Denise, et al.
Publicado: (2019)

Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide
por: Robins, H. Ian, et al.
Publicado: (2018)

Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
por: Palmer, Joshua D., et al.
Publicado: (2021)

Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis
por: Du, Xue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jvtpb13gn4b8b33rblaq173gii